CROI 2019: complications and coinfections in HIV infection

Judith S Currier; Diane V Havlir

CROI 2019: complications and coinfections in HIV infection

Top Antivir Med. 2019 Apr;27(1):34-40.

Authors

Judith S Currier¹, Diane V Havlir²

Affiliations

¹ University of California Los Angeles, Los Angeles, CA, USA.
² University of California San Francisco, San Francisco, CA, USA.

PMID: 31137001
PMCID: PMC6550358

Abstract

The 2019 Conference on Retroviruses and Opportunistic Infections provided a considerable amount of new information on the progress in implementation of strategies to reduce morbidity and mortality from complications and coinfections that occur in people with HIV infection, and on the clinical management of these important problems. This review will address new insights into the prevention and treatment of tuberculosis, fungal infections, sexually transmitted infections, malignancies, and a range of metabolic complications and noncommunicable diseases.

Publication types

Review

MeSH terms

AIDS-Related Opportunistic Infections / diagnosis
AIDS-Related Opportunistic Infections / drug therapy
AIDS-Related Opportunistic Infections / epidemiology*
AIDS-Related Opportunistic Infections / prevention & control
Coinfection / diagnosis
Coinfection / drug therapy
Coinfection / epidemiology*
Coinfection / prevention & control
HIV Infections / complications*
Humans
Metabolic Diseases / diagnosis
Metabolic Diseases / drug therapy
Metabolic Diseases / prevention & control
Mycoses / diagnosis
Mycoses / drug therapy
Mycoses / prevention & control
Neoplasms / diagnosis
Neoplasms / drug therapy
Neoplasms / prevention & control
Tuberculosis / diagnosis
Tuberculosis / drug therapy
Tuberculosis / prevention & control